Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1603-1603
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study
Celine Y. Tan, Calvin J. Chiew, Deanette Pang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. 1343-1348
Open Access | Times Cited: 33
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 263-266
Open Access | Times Cited: 25
Nirmatrelvir Resistance in SARS-CoV-2 Omicron_BA.1 and WA1 Replicons and Escape Strategies
Shuiyun Lan, Grace Neilsen, Ryan L. Slack, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
Analysis of SARS-CoV-2 genome evolutionary patterns
Shubhangi Gupta, Deepanshu Gupta, Sonika Bhatnagar
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 6
The rapid emergence of multiple sublineages of Omicron (B.1.1.529) variant: Dynamic profiling via molecular phylogenetics and mutational landscape studies
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1234-1258
Open Access | Times Cited: 26
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients
Patrick Affeldt, Felix C. Koehler, Karl August Brensing, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2646-2646
Open Access | Times Cited: 22
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Nickolay A. Kryuchkov, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 326-326
Open Access | Times Cited: 10
Impact of vaccination on SARS-CoV-2 evolution and immune escape variants
Deepak Jena, Arup Ghosh, Atimukta Jha, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126153-126153
Closed Access | Times Cited: 3
The Impact of Mutation Sets in Receptor-Binding Domain of SARS-CoV-2 Variants on Stability of the RBD–ACE2 Complex
Mykyta Peka, Viktor Balatsky
Future Virology (2023) Vol. 18, Iss. 4, pp. 225-242
Open Access | Times Cited: 9
Evolution of transient RNA structure–RNA polymerase interactions in respiratory RNA virus genomes
Charlotte V. Rigby, Kimberly R. Sabsay, Karishma Bisht, et al.
Virus Evolution (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 9
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants
Manojit Bhattacharya, Srijan Chatterjee, Sang‐Soo Lee, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101008-101008
Closed Access | Times Cited: 9
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 9
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
Stefania Capone, Francesco Maria Fusco, Stefano Milleri, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101084-101084
Open Access | Times Cited: 7
(+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
Aleksandr S. Filimonov, Оlga I. Yarovaya, Anna V. Zaykovskaya, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2154-2154
Open Access | Times Cited: 11
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants
Ji Woong Kim, Ah Hyun Cho, Ha Gyeong Shin, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 174-174
Open Access | Times Cited: 6
A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough
Manojit Bhattacharya, Abdulrahman Alshammari, Metab Alharbi, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124893-124893
Open Access | Times Cited: 5
Emergence of Genomic Diversity in the Spike Protein of the “Omicron” Variant
Surajit Basak, Pratanu Kayet, Manisha Ghosh, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2132-2132
Open Access | Times Cited: 5
tANCHOR cell-based ELISA approach as a surrogate for antigen-coated plates to monitor specific IgG directed to the SARS-CoV-2 receptor-binding domain
Hubert S. Bernauer, Josef Maier, Norbert Bannert, et al.
Biology Methods and Protocols (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains
Daniel Ivanusic, Josef Maier, Suheda Icli, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109123-109123
Open Access | Times Cited: 1
Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review
Annelise Bocquet-Garçon
Cureus (2024)
Open Access | Times Cited: 1
Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters
Levi Tamming, Diana Duque, Jegarubee Bavananthasivam, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101325-101325
Open Access | Times Cited: 1
On Immunological Studies at Sirius University of Science and Technology
Irina V. Astrakhantseva, Viktoriya G. Krut’, Sergei Chuvpilo, et al.
Molecular Biology (2023) Vol. 57, Iss. 2, pp. 225-234
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top